ATE385502T1 - Avidinmutanten - Google Patents

Avidinmutanten

Info

Publication number
ATE385502T1
ATE385502T1 AT04798288T AT04798288T ATE385502T1 AT E385502 T1 ATE385502 T1 AT E385502T1 AT 04798288 T AT04798288 T AT 04798288T AT 04798288 T AT04798288 T AT 04798288T AT E385502 T1 ATE385502 T1 AT E385502T1
Authority
AT
Austria
Prior art keywords
avidin
dcavd
binding
dual
biotin
Prior art date
Application number
AT04798288T
Other languages
English (en)
Inventor
Henri Rainer Nordlund
Olli Heikki Laitinen
Vesa Pekka Hytoenen
Markku Sakari Kulomaa
Original Assignee
Henri Rainer Nordlund
Olli Heikki Laitinen
Vesa Pekka Hytoenen
Markku Sakari Kulomaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henri Rainer Nordlund, Olli Heikki Laitinen, Vesa Pekka Hytoenen, Markku Sakari Kulomaa filed Critical Henri Rainer Nordlund
Application granted granted Critical
Publication of ATE385502T1 publication Critical patent/ATE385502T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
AT04798288T 2003-11-14 2004-11-15 Avidinmutanten ATE385502T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20031663A FI20031663A0 (fi) 2003-11-14 2003-11-14 Avidiinin mutantteja

Publications (1)

Publication Number Publication Date
ATE385502T1 true ATE385502T1 (de) 2008-02-15

Family

ID=29558634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04798288T ATE385502T1 (de) 2003-11-14 2004-11-15 Avidinmutanten

Country Status (6)

Country Link
US (1) US7960140B2 (de)
EP (1) EP1699817B1 (de)
AT (1) ATE385502T1 (de)
DE (1) DE602004011686T2 (de)
FI (1) FI20031663A0 (de)
WO (1) WO2005047317A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2617827A1 (de) 2007-03-26 2013-07-24 Celexion, LLC Zelloberflächenanzeige, Abtastung und Herstellung von Proteinen von Interesse
US20110207916A1 (en) 2007-11-12 2011-08-25 Novozymes A/S Dual Affinity Polypeptides for Purification
DE102008053892A1 (de) 2008-10-30 2010-05-06 Fachhochschule Gelsenkirchen Medizinisches Implantat mit biofunktionalisierter Oberfläche
FI20086073A0 (fi) * 2008-11-12 2008-11-12 Valtion Teknillinen Pienligandeihin sitoutuvat muunnetut avidiinit
PL2427482T3 (pl) * 2009-05-07 2020-08-24 Chreto Aps Sposób oczyszczania docelowych polipeptydów
EP2400304A1 (de) 2010-06-22 2011-12-28 Centro de Investigación Cooperativa En Biomateriales ( CIC biomaGUNE) Verfahren zur Charakterisierung intermolekularer Interaktionen
WO2012123269A1 (en) 2011-03-11 2012-09-20 Proyecto De Biomedicina Cima, S.L. Immunogenic compositions and methods for their use
EP2505640A1 (de) 2011-03-29 2012-10-03 Neo Virnatech, S.L. Impfstoffzusammensetzungen für vom Birnavirus übertragenen Krankheiten
WO2013018836A1 (ja) * 2011-08-01 2013-02-07 日本たばこ産業株式会社 生物学的試料中の物質を検出する工程において、非特異的結合を抑制する方法、当該方法に使用するための剤
EP2743695A1 (de) 2012-12-12 2014-06-18 Nanogap Sub NM Powder, S.A. Verfahren und Reagenzien zur Detektion von Biomolekülen mittels Lumineszenz
WO2015101666A1 (en) 2014-01-03 2015-07-09 Fundación Biofísica Bizkaia VLPs, METHODS FOR THEIR OBTENTION AND APPLICATIONS THEREOF
WO2018162450A1 (en) 2017-03-06 2018-09-13 Fundación Para La Investigación Médica Aplicada New inmunostimulatory compositions comprising an entity of cold inducible rna-binding protein with an antigen for the activation of dendritic cells
EP4371569A1 (de) 2022-11-16 2024-05-22 Universidad del País Vasco/Euskal Herriko Unibertsitatea Vlps gegen akute myeloische leukämie

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492492B1 (en) * 1998-04-03 2002-12-10 University Of Washington Circularly permuted biotin binding proteins

Also Published As

Publication number Publication date
DE602004011686D1 (de) 2008-03-20
US7960140B2 (en) 2011-06-14
US20090023185A1 (en) 2009-01-22
FI20031663A0 (fi) 2003-11-14
EP1699817B1 (de) 2008-02-06
EP1699817A1 (de) 2006-09-13
WO2005047317A1 (en) 2005-05-26
DE602004011686T2 (de) 2009-02-05

Similar Documents

Publication Publication Date Title
ATE385502T1 (de) Avidinmutanten
YU71800A (sh) Hibridni polipeptidi sa pojačanim farmakokinetičkim osobinama
WO2004020404A3 (en) Modified transferin-antibody fusion proteins
ATE490969T1 (de) Modifizierte transferrin-fusionsproteine
YU1402A (sh) Hibridni polipeptidi sa pojačanim farmakokinetičkim osobinama
WO2004020405A3 (en) Modified transferrin fusion proteins
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
DK0888384T3 (da) Fusionspolypeptid til påvirkning af vekselvirkninger mellem proteiner
WO2006083301A3 (en) Immunogenic compositions comprising hmgb1 polypeptides
DE60333306D1 (de) Modifizierte transferrin-fusionsproteine mit doppelten transferrin-amino- oder carboxy-terminalen domänen
WO2002002636A3 (en) Membrane associated protein zupari
HK1080511A1 (en) Il-1 receptor based antagonists and methods of making and using
WO2001070984A3 (en) Anti-tissue factor antibodies with enhanced anticoagulant potency
WO2000020574A3 (en) Fusions of scaffold proteins with random peptide libraries
DE60033402D1 (de) In-vitro-selektion and wahlweiser nachweis von polypeptiden unter verwendung von festphasenträgern
DK1430133T3 (da) En oplöselig Toll-lignende receptor
WO2002024912A3 (en) Isolated nucleic acid molecules which encode a soluble il-tif/il-22 receptor or binding protein which binds to il-tif/il-22, and uses thereof
DK1773994T3 (da) Polypeptid
ATE466874T1 (de) Mit scytovirin der domäne 1 verwandte polypeptide
DE60221805D1 (de) Peptide mit affinität zu gp120, und ihre verwendungen
DE60330680D1 (de) Transferrin-fusionsproteinbibliotheken
WO2005012341A3 (en) Pichia methanolica secretory signal
WO2003027239A3 (en) Melanin-concentrating hormone receptor antagonist binding protein
WO2007147527A3 (de) Apiase-proteinkonstrukt
CY1116908T1 (el) Ειδικες δεσμευομενες πρωτεϊνες και χρησεις αυτων

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties